http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4153043-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
filingDate 1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-4153043-B2
titleOfInvention Substituted benzoylaminothiazole derivatives and pharmaceuticals containing the same
abstract The present invention relates to a substituted benzoylaminothiazole derivative represented by the following formula (I): <CHEM> wherein X represents an imino group which may be substituted by a lower alkyl group, or an oxygen atom, R<1> represents a cyano group, a lower alkoxycarbonyl group, a lower alkoxycarbonylamino group, a lower alkylsulfonylamino group, a lower alkanoyl or lower alkylsulfonyl group which may be substituted by a halogen atom, a 1-ureido group, a halo-substituted lower alkyl group or a 2-pyrrolylimino group, R<2> and R<3> are the same or different and each independently represents a hydrogen atom or a lower alkyl group and m stands for an integer of 2 to 4, or a salt thereof; and a medicament comprising the compound as an effective ingredient. The compound of the invention is useful as a preventive and therapeutic agent for epigastric dyscomfort, nausea, vomiting, heartburn, anorexia, bellyache, abdominal flatulence, chronic gastritis or the like.
priorityDate 1996-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466313741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467547565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468316854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467547566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467547564

Total number of triples: 25.